Our results show that ESCC patients with higher C20orf54 expression had a longer postoperative survival time than those with lower C20orf54 expression, but the Cox analysis reveals that C20orf54 defective expression could not serve as a significant independent prognostic factor to predict the risk of death. This evidence concerns the gene SLC52A3 and esophageal squamous cell carcinoma.